Puretech Health PLC (LON:PRTC)‘s stock had its “buy” rating reissued by equities research analysts at Numis Securities Ltd in a report issued on Wednesday. They presently have a GBX 246 ($3.18) target price on the stock. Numis Securities Ltd’s price objective suggests a potential upside of 76.98% from the company’s current price.

PRTC has been the topic of several other research reports. Jefferies Group LLC reaffirmed a “buy” rating and issued a GBX 255 ($3.30) price objective on shares of Puretech Health PLC in a research report on Friday, June 9th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 259 ($3.35) price objective on shares of Puretech Health PLC in a research report on Wednesday, May 10th. Liberum Capital reaffirmed a “buy” rating and issued a GBX 248 ($3.21) price objective on shares of Puretech Health PLC in a research report on Wednesday, May 10th. Finally, N+1 Singer reaffirmed a “buy” rating and issued a GBX 256 ($3.31) price objective on shares of Puretech Health PLC in a research report on Tuesday, May 16th. Five equities research analysts have rated the stock with a buy rating, Puretech Health PLC presently has a consensus rating of “Buy” and an average target price of GBX 246.80 ($3.19).

Shares of Puretech Health PLC (LON:PRTC) opened at 139.00 on Wednesday. Puretech Health PLC has a 12-month low of GBX 110.00 and a 12-month high of GBX 170.00. The company has a 50-day moving average of GBX 132.82 and a 200 day moving average of GBX 120.75. The company’s market cap is GBX 323.47 million.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.watchlistnews.com/puretech-health-plc-prtc-stock-rating-reaffirmed-by-numis-securities-ltd/1535461.html.

Puretech Health PLC Company Profile

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Analyst Recommendations for Puretech Health PLC (LON:PRTC)

Receive News & Ratings for Puretech Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.